Literature DB >> 20064860

Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts.

Marlene R Miller1, Michael Griswold, J Mitchell Harris, Gayane Yenokyan, W Charles Huskins, Michele Moss, Tom B Rice, Debra Ridling, Deborah Campbell, Peter Margolis, Stephen Muething, Richard J Brilli.   

Abstract

OBJECTIVE: Despite the magnitude of the problem of catheter-associated bloodstream infections (CA-BSIs) in children, relatively little research has been performed to identify effective strategies to reduce these complications. In this study, we aimed to develop and evaluate effective catheter-care practices to reduce pediatric CA-BSIs. STUDY DESIGN AND METHODS: Our study was a multi-institutional, interrupted time-series design with historical control data and was conducted in 29 PICUs across the United States. Two central venous catheter-care practice bundles comprised our intervention: the insertion bundle of pediatric-tailored care elements derived from adult efforts and the maintenance bundle derived from the Centers for Disease Control and Prevention recommendations and expert pediatric clinician consensus. The bundles were deployed with quality-improvement teaching and methods to support their adoption by teams at the participating PICUs. The main outcome measures were the rate of CA-BSIs from January 2004 to September 2007 and compliance with each element of the insertion and maintenance bundles from October 2006 to September 2007.
RESULTS: Average CA-BSI rates were reduced by 43% across 29 PICUs (5.4 vs 3.1 CA-BSIs per 1000 central-line-days; P < .0001). By September 2007, insertion-bundle compliance was 84% and maintenance-bundle compliance was 82%. Hierarchical regression modeling showed that the only significant predictor of an observed decrease in infection rates was the collective use of the insertion and maintenance bundles, as demonstrated by the relative rate (RR) and confidence intervals (CIs) (RR: 0.57 [95% CI: 0.45-0.74]; P < .0001). We used comparable modeling to assess the relative importance of the insertion versus maintenance bundles; the results showed that the only significant predictor of an infection-rate decrease was maintenance-bundle compliance (RR: 0.41 [95% CI: 0.20-0.85]; P = .017).
CONCLUSIONS: In contrast with adult ICU care, maximizing insertion-bundle compliance alone cannot help PICUs to eliminate CA-BSIs. The main drivers for additional reductions in pediatric CA-BSI rates are issues that surround daily maintenance care for central lines, as defined in our maintenance bundle. Additional research is needed to define the optimal maintenance bundle that will facilitate elimination of CA-BSIs for children.

Entities:  

Mesh:

Year:  2010        PMID: 20064860     DOI: 10.1542/peds.2009-1382

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  82 in total

1.  Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC).

Authors:  V D Rosenthal; B Ramachandran; W Villamil-Gómez; A Armas-Ruiz; J A Navoa-Ng; L Matta-Cortés; M Pawar; A Nevzat-Yalcin; M Rodríguez-Ferrer; R D Yıldızdaş; A Menco; R Campuzano; V D Villanueva; L F Rendon-Campo; A Gupta; O Turhan; N Barahona-Guzmán; O O Horoz; P Arrieta; J M Brito; M C V Tolentino; Y Astudillo; N Saini; N Gunay; G Sarmiento-Villa; E Gumus; A Lagares-Guzmán; O Dursun
Journal:  Infection       Date:  2012-02-28       Impact factor: 3.553

2.  Impact of infection control training for interns on PICU-acquired bloodstream infections in a middle-income country.

Authors:  Yun Yun Ng; Mohamed El-Amin Abdel-Latif; Chin Seng Gan; Anis Siham; Hasimah Zainol; Lucy Chai See Lum
Journal:  Singapore Med J       Date:  2015-09       Impact factor: 1.858

3.  State-Mandated Hospital Infection Reporting Is Not Associated With Decreased Pediatric Health Care-Associated Infections.

Authors:  Michael L Rinke; David G Bundy; Fizan Abdullah; Elizabeth Colantuoni; Yiyi Zhang; Marlene R Miller
Journal:  J Patient Saf       Date:  2015-09       Impact factor: 2.844

4.  Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.

Authors:  Michael L Rinke; David G Bundy; Aaron M Milstone; Kristin Deuber; Allen R Chen; Elizabeth Colantuoni; Marlene R Miller
Journal:  Jt Comm J Qual Patient Saf       Date:  2013-08

Review 5.  Novel initiatives of the National Institutes of Health to support congenital heart disease research.

Authors:  Kristin M Burns; Gail D Pearson; Jonathan R Kaltman
Journal:  Curr Opin Pediatr       Date:  2013-10       Impact factor: 2.856

6.  Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.

Authors:  Matthew Kelly; Margaret Conway; Kathleen Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

7.  Retrospective outcomes of glucose control in critically ill children.

Authors:  Sarah B Kandil; Debra Spear; Neal J Thomas; Stuart A Weinzimer; Edward Vincent S Faustino
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 8.  A contemporary approach to the prevention of peritoneal dialysis-related peritonitis in children: the role of improvement science.

Authors:  Allison Redpath Mahon; Alicia M Neu
Journal:  Pediatr Nephrol       Date:  2016-10-18       Impact factor: 3.714

9.  Variation in Preventive Care in Children Receiving Chronic Glucocorticoid Therapy.

Authors:  Matthew L Basiaga; Evanette K Burrows; Michelle R Denburg; Kevin E Meyers; Andrew B Grossman; Petar Mamula; Robert W Grundmeier; Jon M Burnham
Journal:  J Pediatr       Date:  2016-09-09       Impact factor: 4.406

Review 10.  Are central line bundles and ventilator bundles effective in critically ill neonates and children?

Authors:  Charlotte A Smulders; Josephus P J van Gestel; Albert P Bos
Journal:  Intensive Care Med       Date:  2013-04-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.